Literature DB >> 5909480

Cycloguanil pamoate in the treatment and suppression of malaria in the Gambia, West Africa.

I A McGregor, K Williams, G H Walker, A K Rahman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5909480      PMCID： PMC1844242          DOI： 10.1136/bmj.1.5489.695

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  THE ACTIVITY OF A REPOSITORY FORM OF 4,6-DIAMINO-1(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE AGAINST INFECTIONS WITH PLASMODIUM CYNOMOLGI.

Authors:  L H SCHMIDT; R N ROSSAN; K F FISHER
Journal:  Am J Trop Med Hyg       Date:  1963-07       Impact factor: 2.345

2.  THE EFFECT OF A REPOSITORY PREPARATION OF THE DIHYDROTRIAZINE METABOLITE OF CHLORGUANIDE, CI-501, AGAINST THE CHESSON STRAIN OF PLASMODIUM VIVAX IN MAN.

Authors:  G R COATNEY; P G CONTACOS; J S LUNN; J W KILPATRICK; H A ELDER
Journal:  Am J Trop Med Hyg       Date:  1963-07       Impact factor: 2.345

3.  A metabolite of paludrine with high antimalarial activity.

Authors:  H C CARRINGTON; A F CROWTHER; D G DAVEY; A A LEVI; F L ROSE
Journal:  Nature       Date:  1951-12-22       Impact factor: 49.962

4.  CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA.

Authors:  J S LUNN; W CHIN; P G CONTACOS; G R COATNEY
Journal:  Am J Trop Med Hyg       Date:  1964-11       Impact factor: 2.345

5.  LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG.

Authors:  P E THOMPSON; B J OLSZEWSKI; E F ELSLAGER; D F WORTH
Journal:  Am J Trop Med Hyg       Date:  1963-07       Impact factor: 2.345
  5 in total
  4 in total

1.  Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.

Authors:  L H Schmidt; R N Rossan
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

Review 2.  Mass drug administration for malaria.

Authors:  Eugenie Poirot; Jacek Skarbinski; David Sinclair; S Patrick Kachur; Laurence Slutsker; Jimee Hwang
Journal:  Cochrane Database Syst Rev       Date:  2013-12-09

Review 3.  Designing the next generation of medicines for malaria control and eradication.

Authors:  Jeremy N Burrows; Rob Hooft van Huijsduijnen; Jörg J Möhrle; Claude Oeuvray; Timothy N C Wells
Journal:  Malar J       Date:  2013-06-06       Impact factor: 2.979

Review 4.  New developments in anti-malarial target candidate and product profiles.

Authors:  Jeremy N Burrows; Stephan Duparc; Winston E Gutteridge; Rob Hooft van Huijsduijnen; Wiweka Kaszubska; Fiona Macintyre; Sébastien Mazzuri; Jörg J Möhrle; Timothy N C Wells
Journal:  Malar J       Date:  2017-01-13       Impact factor: 2.979
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.